These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 6320035

  • 1. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM, Beaman OJ.
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [Abstract] [Full Text] [Related]

  • 2. Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex.
    Gandolfi O, Barbaccia ML, Chuang DM, Costa E.
    Neuropharmacology; 1983 Jul; 22(7):927-9. PubMed ID: 6312356
    [Abstract] [Full Text] [Related]

  • 3. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M, Tsukamoto T.
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [Abstract] [Full Text] [Related]

  • 4. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM, Maxwell RA, Cooper BR, Soroko FE.
    Adv Biochem Psychopharmacol; 1982 Dec; 31():277-86. PubMed ID: 6282058
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E.
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005.
    Nowak G, Arnt J, Hyttel J, Svendsen O.
    J Neural Transm; 1985 Sep; 64(3-4):227-38. PubMed ID: 2418155
    [Abstract] [Full Text] [Related]

  • 16. Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following noradrenergic or serotonergic denervation.
    Eison AS, Yocca FD, Gianutsos G.
    J Neural Transm Gen Sect; 1991 Sep; 84(1-2):19-32. PubMed ID: 1647168
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
    Sartori DP, Oliveira NF, Valentim JT, Silva DMA, Mallman ASV, Oliveira ICM, Chaves RC, Capibaribe VC, Carvalho AMR, Rebouças MO, Macedo DS, Chaves Filho AJM, Fonteles MMF, Gutierrez SJC, Barbosa-Filho JM, Mottin M, Andrade CH, Sousa FCF.
    Behav Brain Res; 2020 Apr 06; 383():112487. PubMed ID: 31987932
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.